How to impress at interview

You’ve been invited for an interview for your dream role. You need to stand head and shoulders above the competition, and it’s important to...

You’re about to start your new job. How do you make the most of...

When you’re about to start your new job, chances are you’re feeling on top of the world. You were chosen above everyone else, and...

Sue Mahony President of Lilly Oncology to retire

Eli Lilly and Company have announced that Sue Mahony, Ph.D., senior vice president of Lilly and president of Lilly Oncology, will retire at the...

Maximise your skills for success

  Become a top sales performer by harnessing and developing your skills for maximum success. Working in pharma sales is a demanding and challenging occupation. Employers...

Back on the pharma job market – what’s out there?

Finding yourself back on the job market after years can be daunting. How can recruiters work with seasoned pharma professionals to offer them a...

A week in the life of a modern pharma pro

  Pf Award winner Raheel Mirza takes us on a week-long tour of life in modern pharma. What is a week in pharma? According to Raheel...

How to make an impression at an assessment centre

  The pharmaceutical industry’s recruitment processes are notoriously rigorous. They’re looking for the best of the best and there are many ways they have of...

Adele Paterson on how pharma donations are saving lives

  Adele Paterson and the team at International Health Partners are passionate about exporting medicines to the most desperate people in the world. When we think...

Cancer Research UK appoints new Senior Clinical Advisor

Cancer Research UK has announced the appointment of Dr James Larkin as a new Senior Clinical Advisor in clinical research. Dr Larkin’s new role aims...

NeoPhore Appoints Jeffrey Roix as Chief Executive Officer

NeoPhore have appointed Jeffrey Roix as Chief Executive Officer, with immediate effect.

Latest articles

Pfizer & Lilly announce results of tanezumab trial for osteoarthritis pain

Pfizer Inc. and Eli Lilly and Company have announced that a 16-week Phase 3 study in patients with osteoarthritis (OA) pain evaluating subcutaneous administration...

Vyriad’s colorectal cancer oncolytic virus – Voyager-V1

Vyriad Inc., a clinical-stage, privately held biotechnology company focused on the development of powerful first-in class oncolytic virotherapies, announces a collaboration agreement with Merck...

Kisqali ® is first breast cancer therapy specifically for premenopausal women

Novartis has announced a new approval for Kisqali ® (ribociclib) from the US Food and Drug Administration (FDA) for women with hormone-receptor positive, human...